A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis
- PMID: 22942208
- PMCID: PMC3478143
- DOI: 10.1093/cid/cis716
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis
Abstract
Background: Poor access to diagnosis stymies control of visceral leishmaniasis (VL). Antibody-detecting rapid diagnostic tests (RDTs) can be performed in peripheral health settings. However, there are many brands available and published reports of variable accuracy.
Methods: Commercial VL RDTs containing bound rK39 or rKE16 antigen were evaluated using archived human sera from confirmed VL cases (n = 750) and endemic non-VL controls (n = 754) in the Indian subcontinent (ISC), Brazil, and East Africa to assess sensitivity and specificity with 95% confidence intervals. A subset of RDTs were also evaluated after 60 days' heat incubation (37°C, 45°C). Interlot and interobserver variability was assessed.
Results: All test brands performed well against ISC panels (sensitivity range, 92.8%-100%; specificity range, 96%-100%); however, sensitivity was lower against Brazil and East African panels (61.5%-91% and 36.8%-87.2%, respectively). Specificity was consistently > 95% in Brazil and ranged between 90.8% and 98% in East Africa. Performance of some products was adversely affected by high temperatures. Agreement between lots and readers was good to excellent (κ > 0.73-0.99).
Conclusions: Diagnostic accuracy of VL RDTs varies between the major endemic regions. Many tests performed well and showed good heat stability in the ISC; however, reduced sensitivity against Brazilian and East African panels suggests that in these regions, used alone, several RDTs are inadequate for excluding a VL diagnosis. More research is needed to assess ease of use and to compare performance using whole blood instead of serum and in patients coinfected with human immunodeficiency virus.
Similar articles
-
Comparative evaluation of blood and serum samples in rapid immunochromatographic tests for visceral leishmaniasis.J Clin Microbiol. 2013 Dec;51(12):3955-9. doi: 10.1128/JCM.01232-13. Epub 2013 Sep 18. J Clin Microbiol. 2013. PMID: 24048530 Free PMC article.
-
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease.Cochrane Database Syst Rev. 2014 Jun 20;2014(6):CD009135. doi: 10.1002/14651858.CD009135.pub2. Cochrane Database Syst Rev. 2014. PMID: 24947503 Free PMC article. Review.
-
Performance of rK39-based immunochromatographic rapid diagnostic test for serodiagnosis of visceral leishmaniasis using whole blood, serum and oral fluid.PLoS One. 2020 Apr 2;15(4):e0230610. doi: 10.1371/journal.pone.0230610. eCollection 2020. PLoS One. 2020. PMID: 32240188 Free PMC article.
-
A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh.Parasit Vectors. 2015 Jun 16;8:331. doi: 10.1186/s13071-015-0935-x. Parasit Vectors. 2015. PMID: 26077956 Free PMC article.
-
Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis.PLoS Negl Trop Dis. 2012 Jan;6(1):e1484. doi: 10.1371/journal.pntd.0001484. Epub 2012 Jan 31. PLoS Negl Trop Dis. 2012. PMID: 22303488 Free PMC article. Review.
Cited by
-
Evaluation of a new brand of immunochromatographic test for visceral leishmaniasis in Brazil made available from 2018.Rev Inst Med Trop Sao Paulo. 2018;60:e49. doi: 10.1590/s1678-9946201860049. Epub 2018 Sep 13. Rev Inst Med Trop Sao Paulo. 2018. PMID: 30231169 Free PMC article.
-
Control of visceral leishmaniasis in East Africa: fragile progress, new threats.BMJ Glob Health. 2021 Aug;6(8):e006835. doi: 10.1136/bmjgh-2021-006835. BMJ Glob Health. 2021. PMID: 34413075 Free PMC article. No abstract available.
-
A panel of recombinant Leishmania donovani cell surface and secreted proteins identifies LdBPK_323600.1 as a serological marker of symptomatic infection.mBio. 2024 May 8;15(5):e0085924. doi: 10.1128/mbio.00859-24. Epub 2024 Apr 19. mBio. 2024. PMID: 38639536 Free PMC article.
-
Development of a chimeric protein based on a proteomic approach for the serological diagnosis of human tegumentary leishmaniasis.Appl Microbiol Biotechnol. 2021 Sep;105(18):6805-6817. doi: 10.1007/s00253-021-11518-1. Epub 2021 Aug 25. Appl Microbiol Biotechnol. 2021. PMID: 34432132
-
Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study.PLoS Negl Trop Dis. 2015 May 12;9(5):e0003738. doi: 10.1371/journal.pntd.0003738. eCollection 2015 May. PLoS Negl Trop Dis. 2015. PMID: 25965564 Free PMC article.
References
-
- Matlashewski G, Arana B, Kroeger A, et al. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis. 2011;11:322–5. - PubMed
-
- Harith AE, Kolk AH, Kager PA, et al. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1986;80:583–6. - PubMed
-
- Boelaert M, El-Safi S, Hailu A, et al. Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg. 2008;102:32–40. - PubMed